Methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride
C14H26Cl2N4O4 — CID 70376317
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride
Methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride (PubChem CID 70376317) has the molecular formula C14H26Cl2N4O4 and a molecular weight of 385.29 g/mol. Its IUPAC name is methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride.
Molecular Properties
| Compound Name | Methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride |
|---|---|
| PubChem CID | 70376317 |
| Molecular Formula | C14H26Cl2N4O4 |
| Molecular Weight | 385.29 g/mol |
| Exact Mass | 384.13 |
| IUPAC Name | methyl 3-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-hydroxy-5-methylhexanoate;dihydrochloride |
| SMILES | COC(=O)C(O)C(CC(C)C)NC(=O)[C@@H](N)Cc1cnc[nH]1.Cl.Cl |
| InChI | InChI=1S/C14H24N4O4.2ClH/c1-8(2)4-11(12(19)14(21)22-3)18-13(20)10(15)5-9-6-16-7-17-9;;/h6-8,10-12,19H,4-5,15H2,1-3H3,(H,16,17)(H,18,20);2*1H/t10-,11?,12?;;/m0../s1 |
| InChIKey | QNTRUTMMMITFPP-JKTOABMASA-N |
| XLogP | 0.19 |
| TPSA | 130.33 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.29 |
| LogP ≤ 5 | 0.19 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70376317 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.